Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Prostate cancer (PCa) is the most common non-cutaneous cancer in men and a notable cause of cancer mortality when it metastasises. The unfolded protein response (UPR) can be cytoprotective but when acutely activated can lead to cell death. In this study, we sought to enhance the acute activation of the UPR using radiation and ONC201, an UPR activator. Treating PCa cells with ONC201 quickly increased the expression of all the key regulators of the UPR and reduced the oxidative phosphorylation, with cell death occurring 72 h later. We exploited this time lag to sensitize prostate cancer cells to radiation through short-term treatment with ONC201. To understand how priming occurred, we performed RNA-Seq analysis and found that ONC201 suppressed the expression of cell cycle and DNA repair factors. In conclusion, we have shown that ONC201 can prime enhanced radiation response.

Original publication

DOI

10.1038/s41598-021-83215-y

Type

Journal article

Journal

Sci Rep

Publication Date

19/02/2021

Volume

11

Keywords

Antineoplastic Agents, Cell Cycle, Cell Death, Cell Line, Tumor, Cell Survival, DNA Repair, Gene Expression Regulation, Neoplastic, Humans, Imidazoles, Male, Mitochondria, Prostatic Neoplasms, Pyridines, Pyrimidines, Radiation Tolerance, Signal Transduction, Unfolded Protein Response